References
- Alison MG, Peter RF. (1997). Pancreatic and extra-pancreatic effects of the traditional antidiabetic plant Medicago sativa. Br J Nutr, 78, 325–334.
- Bhattacharya SK, Satyan KS. (1997). Experimental methods for evaluation of psychotropic agents in rodents: I–Anti-anxiety agents. Indian J Exp Biol, 35, 565–575.
- BHMA (1996). British Herbal Pharmacopoeia (BHP). Bournemouth, British Herbal Medical Association.
- Carobrez AP, Bertoglio LJ. (2005). Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neurosci Biobehav Rev, 29, 1193–1205.
- Duke J. (1985). Handbook of Medicinal Herbs. Boca Raton Florida, USA: CRC Press.
- Farnsworth NR. (1966). Biological and phytochemical screening of plants. J Pharm Sci, 55, 225–276.
- Finkler K. (1985). Spiritualist Healers in Mexico. South Hadley: MA, Bergin & Garvey.
- Inamul H. (2004). Safety of medicinal plants. Pak J Med Res 43, 1–8.
- Kessler RC, Wang PS. (2008). The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health, 29, 115–129.
- Khaleel AE, Mohamed Z, Shohda GAE, Mohamed SH, Sattar EA. (2005). Study of hypocholesterolemic and antiatherosclerotic properties of Medicago sativa L. cultivated in Egypt. J Food Drug Anal, 13, 212–218.
- Kulkarni SK, Reddy DS. (1996). Animal behavioral models for testing antianxiety agents. Methods Find Exp Clin Pharmacol, 18, 219–230.
- Kundan SB, Anupam S. (2011a). Phytochemical and pharmacological potential of Medicago sativa, A review. Pharm Biol, 49, 211–220.
- Kundan SB, Anupam S. (2011b). Evaluation of antioxidant and cerebroprotective effect of Medicago sativa Linn. against ischemia and reperfusion insult. eCAM [Online]. Available at: http://www.hindawi.com/journals/ecam/2011/792167/. Accessed on 15 April 2011.
- Kunovac JL, Stahl SM. (1995). Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am, 18, 895–909.
- Lader M, Morton S. (1991). Benzodiazepine problems. Br J Addict, 86, 823–828.
- Lin JY, Tang CY. (2007). Determination of total phenolic and flavonoid contents in selected fruits and vegetables, as well as their stimulatory effect on mouse splenocyte proliferation. Food Chem, 101, 140–148.
- Mills S. (1994). The Complete Guide to Modern Herbalism. Thorsons: Great Britain, UK.
- Mitchell HW. (1983) The British Herbal Pharmacopoeia. The British Herbal Medicine Association: 140.
- Olatunji BO, Cisler JM, Tolin DF. (2007). Quality of life in the anxiety disorders: A meta-analytic review. Clin Psychol Rev, 27, 572–581.
- Rabbania M, Sajjadib SE, Zarei HR. (2003). Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice. J Ethnopharmacol, 89, 271–276.
- Reilly P. (1989). Clinical application-Medicago sativa extracts. J Naturopath Med, 1, 455–460.
- Reynolds EH. (2003). Brain and mind: A challenge for WHO. Lancet, 361, 1924–1925.
- Une HD, Sarveiya VP, Pal SC, Kasture VS, Kasture SB. (2001). Nootropic and anxiolytic activity of saponins of Albizzia lebbeck leaves. Pharmacol Biochem Behav, 69, 439–444.
- WHO. (2003). The World Health Report- Investing in Mental Health. WHO, Department of mental health and substance dependence, Avenue Appia, Geneva, Switzerland. Available at: http://www.who.int/mental_health/en/investing_in_mnh_final.pdf. Accessed on 07 April 2011.
- WHO. (2004). World Health Organization. The World Health Report 2004, Changing History, Annex Table 3, Burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions, estimates for 2002. Available at: http://www.who.int/whr/(2004/en/report04_en.pdf. Accessed on 17 Jan 2011.